Dimension Therapeutics Inc buy melinda
Start price
27.01.17
/
50%
€4.15
Target price
10.03.17
€9.02
Performance (%)
-57.61%
End price
10.03.17
€1.76
Summary
This prediction ended on 10.03.17 with a price of €1.76. Massive losses of -57.61% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dimension Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
Comments by melinda for this prediction
In the thread Dimension Therapeutics Inc diskutieren
Hämophilie
Phase 1 der 31/01/2017
(Vom Mitglied beendet)
Stopped prediction by melinda for Dimension Therapeutics Inc
Dimension Therapeutics Inc
Start price
Target price
Perf. (%)
€1.97
13.03.17
13.03.17
€4.51
25.08.17
25.08.17
38.54%
25.08.17
25.08.17


